Exogene Companies
Exogene is a biotechnology company that focuses on accelerating the discovery of T-cell-receptor (TCR)-based cancer immunotherapies for solid tumors. They utilize deep learning and high-throughput TCR-antigen screening to identify new tumor targets and develop safe and effective TCRs for therapeutic application. Their goal is to develop better TCR-based immunotherapies faster and at a lower cost. Exogene's generative AI platform allows for comprehensive mining of the TCR sequence space to discover novel, high-affinity, and non-cross-reactive TCRs against targets shared across patients and tumor types. The company is led by Federico, a computational biologist with expertise in mathematical modeling and molecular biophysics, and Andrea, an experienced machine learning scientist.
